Missing/wrong data?
Log in to edit
An open-label trial in Friedreich ataxia suggests clinical benefit with high-dose resveratrol, without effect on frataxin levels
scientific article published on 07 April 2015
Author/s
author: Kevin Croft, Trevor A Mori, Brigitte Sturm, Adam P. Vogel, Monique Ryan, Paul J. Lockhart, Martin Delatycki, Marguerite Evans-Galea, Eppie M. Yiu
Work details
Publication date
April 7, 2015
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.